ANIP ANI Pharmaceuticals Inc

NASDAQ
$70.19

ANI Pharmaceuticals Inc (ANIP) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below ANIP's own trailing one-year pace, with 86% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
4
8 transactions
Purchases
$0
0 shares
Sales
$1.7M
21,425 shares
Net activity
-$1.7M
purchases less sales

How much of that selling was preplanned? 86% planned / 14% discretionary

10b5-1 plan sales $1.4M 7 transactions · 18,263 shares
Discretionary sales $243.5K 1 transaction · 3,162 shares

Largest single sale: $401.2K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $72.80 $207.5K 171,843 −1.6% of holding
Lalwani Nikhil PRESIDENT & CEO Sell 10b5-1 5,400 $74.30 $401.2K 344,489 −1.5% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $75.48 $37.7K 74,424 −0.7% of holding
Gutwerg Ori SVP, GENERICS Sell 3,162 $77.00 $243.5K 75,534 −4% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $81.36 $231.9K 174,693 −1.6% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $81.84 $40.9K 77,390 −0.6% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 3,313 $86.00 $284.9K 177,543 −1.8% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $84.12 $239.7K 177,543 −1.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.